Physician profile
Rajul Kothari
NPI 1518160720
$1,540.09
in general payments reported to CMS, 2019-2025
23 companies · $25.77 in 2025
The $25.77 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $183 · 2021: $86.55 · 2022: $1,042 · 2023: $32.10 · 2024: $26.24 · 2025: $25.77.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $808.80 | 2022 | |
| Sirtex Medical INC | $95.25 | 2019 | |
| Merck Sharp & Dohme LLC | $55.47 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $54.73 | 2022-2023 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $49.57 | 2020-2022 | |
| Glaxosmithkline, LLC. | $48.09 | 2022-2024 | Jemperli, Zejula |
| Pharmacyclics LLC, An Abbvie Company | $43.33 | 2019-2020 | |
| Scynexis, INC. | $42.04 | 2022 | |
| Eisai INC. | $41.83 | 2020 | |
| Seagen INC. | $34.69 | 2020 | |
| Novartis Pharmaceuticals Corporation | $34.13 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $29.54 | 2020 | |
| Myovant Sciences INC. | $28.53 | 2022 | |
| Abbvie INC. | $25.77 | 2025 | |
| Incyte Corporation | $22.48 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $19.83 | 2021 | |
| Agios Pharmaceuticals, INC. | $18.51 | 2022 | |
| Daiichi Sankyo INC. | $17.50 | 2020 | |
| Lilly USA, LLC | $17.46 | 2022 | |
| Sobi, INC | $16.08 | 2022 | |
| Medtronic USA, INC. | $12.95 | 2020 | |
| Kite Pharma, INC. | $11.91 | 2021 | |
| Clovis Oncology, INC. | $11.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajul Kothari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.